- Home
- Media Center
- Press releases
- Innovative Medicine
Innovative Medicine
New Study Shows Circulating Tumor Cell Enumeration – as Part of Composite Biomarker Panel –May Serve as a Surrogate for Efficacy Response in Metastatic Castration-Resistant Prostate Cancer
First study to find patients with unfavorable risk profile at 12 weeks have worse prognosis and should be considered for alternative treatments
Japanese Health Authority Approves SOVRIAD™ For The Treatment Of Genotype-1 Chronic HCV Infection
Japan is the first country in the world where SOVRIAD™ is approved
Janssen Healthcare Innovation Launches Care4Today™ Mobile Health Manager 2.0
Free two-way secure messaging platform, mobile app and website introduces new Care4Charity™ and Care4Family™ features to motivate users to take medications on schedule and support caregivers
STELARA® (Ustekinumab) Receives FDA Approval To Treat Active Psoriatic Arthritis
First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis
SIMPONI® Receives European Commission Approval For Treatment Of Moderately To Severely Active Ulcerative Colitis
First and Only Subcutaneous Biologic Treatment Administered Every Four Weeks Approved for Ulcerative Colitis
STELARA® Receives European Commission Approval For Treatment Of Active Psoriatic Arthritis
Approval marks a new biologic treatment with alternative mechanism for complex inflammatory disease
Pooled Analysis Confirms XARELTO® has Similar Efficacy and Reduces the Incidence of Major Bleeding by Nearly Half Compared to Standard of Care in Treatment of DVT and PE
Analysis Published in the Thrombosis Journal